Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation
Abstract
We investigated the molecular effects of 3,4,2',4'-tetrahydroxychalcone (butein) treatment in two human hepatoma cancer cell lines-HepG2 and Hep3B. Butein treatment inhibited cancer cell growth by inducing G(2)/M phase arrest and apoptosis. Butein-induced G(2)/M phase arrest was associated with increased ATM, Chk1, and Chk2 phosphorylations and reduced cdc25C levels. Additionally, butein treatment enhanced inactivated phospho-Cdc2 levels, reduced Cdc2 kinase activity, and generated reactive oxygen species (ROS) that was accompanied by JNK activation. The extent of butein-induced G(2)/M phase arrest significantly decreased following pretreatment with N-acetyl-l-cysteine or glutathione and following JNK phosphorylation reduction by SP600125. Both N-acetyl-l-cysteine and glutathione also decreased butein-mediated apoptosis. Taken together, these results imply a critical role of ROS and JNK in the anticancer effects of butein.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High levels of ROS trigger cell cycle arrest and cancer cell death.
“High levels of ROS have been shown to trigger cell cycle arrest and cancer cell death (Moon et al. 2010).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Moon et al. 2010
Cites
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032 · see citing works
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513 · see citing works
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320 · see citing works
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242 · see citing works
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118 · see citing works
cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2
Gautier, J., Solomon, M. J., Booher, R. N., Bazán, J. F., & Kirschner, M. W. (1991) · Cell · doi:10.1016/0092-8674(91)90583-k · Cited by 843 · see citing works
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 830 · see citing works
Reactive oxygen species in tumorigenesis.
Feig, D. I., Reid, T. M., & Loeb, L. A. (1994) · PubMed · Cited by 472 · see citing works
Ling, Y., Liebes, L., Zou, Y., & Perez-Soler, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302559200 · Cited by 458 · see citing works
Stennicke, H. R., & Salvesen, G. S. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(98)00133-2 · Cited by 373 · see citing works
Ka, H., Park, H.-J., Jung, H., Choi, J.-W., Cho, K.-S., Ha, J., & Lee, K. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00238-6 · Cited by 361 · see citing works
Reactive oxygen species and the mitochondrial signaling pathway of cell death.
Bras, M. L., Clément, M.-V., Pervaiz, S., & Brenner, C. (2005) · PubMed · doi:10.14670/hh-20.205 · Cited by 359 · see citing works
Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1
Melchionna, R., Chen, X., Blasina, A., & McGowan, C. H. (2000) · Nature Cell Biology · doi:10.1038/35036406 · Cited by 307 · see citing works
OH, S., & Lim, S. S. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.018 · Cited by 283 · see citing works
Flavonoids Inhibit Cell Growth and Induce Apoptosis in B16 Melanoma 4A5 Cells
Iwashita, K., Kobori, M., Yamaki, K., & Tsushida, T. (2000) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.64.1813 · Cited by 256 · see citing works
Molecular pathogenesis of human hepatocellular carcinoma
Wang, X. W., Hussain, S. P., Huo, T., Wu, C.-G., Forgues, M., Hofseth, L. J., Bréchot, C., & Harris, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00253-6 · Cited by 246 · see citing works
Moungjaroen, J., Nimmannit, U., Callery, P. S., Wang, L., Azad, N., Lipipun, V., Pithi Chanvorachote, B., & Rojanasakul, Y. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110965 · Cited by 217 · see citing works
The ATM protein is required for sustained activation of NF-κB following DNA damage
Piret, B., Schoonbroodt, S., & Piette, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202541 · Cited by 176 · cited 1× · see citing works
“An accumulation of ROS can severely damage cellular macromolecules, especially DNA, and induce G2/M phase arrest through ataxia telangiectasia mutant (ATM) activation [7].”
BackgroundZhang, Y., & Chen, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3361 · Cited by 173 · see citing works
Systemic therapy for advanced hepatocellular carcinoma: a review
Nowak, A. K., Chow, P. K. H., & Findlay, M. P. N. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.027 · Cited by 168 · see citing works
Kim, B.-C., Kim, H.-G., Lee, S.-A., Lim, S., Park, E.-H., Kim, S., & Lim, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.025 · Cited by 159 · see citing works
Kuo, P., Chen, C., & Hsu, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1089 · Cited by 152 · see citing works
Haddad, J. J. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.02.002 · Cited by 137 · see citing works
Jang, H.-S., Kook, S., Son, Y., et al. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.08.010 · Cited by 120 · see citing works
Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation
Yit, C. C., & Das, N. P. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90147-3 · Cited by 117 · see citing works
Baicalin induces apoptosis via mitochondrial pathway as prooxidant
Ueda, S., Nakamura, H., Masutani, H., et al. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00115-8 · Cited by 110 · see citing works
Wang, Y., Chan, F. L., Chen, S., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.014 · Cited by 106 · see citing works
Samoszuk, M. K., Tan, J., & Chorn, G. (2005) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-5-5 · Cited by 83 · see citing works
Kim, N., Pae, H., Oh, G., et al. (2001) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2001.d01-114.x · Cited by 65 · see citing works
Ham, Y., Jin-Hee, L., Na, H., Choi, J., Park, B.-D., Yim, H., & Lee, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109926 · Cited by 58 · see citing works
Iwamaru, A., Iwado, E., Kondo, S., Newman, R. A., Vera, B., Rodrı́guez, A. D., & Kondo, Y. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0422 · Cited by 55 · see citing works
Ubisemiquinone radicals in liver: Implications for a mitochondrial Q cycle in vivo
Davies, K. J. A., & Hochstein, P. E. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(82)80138-1 · Cited by 44 · see citing works
Lee, S. H., Seo, G. S., Kim, H. S., Woo, S. W., Ko, G., & Sohn, D. H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.004 · Cited by 40 · see citing works
Detection of Oxidative Stress in Lymphocytes Using Dichlorodihydrofluorescein Diacetate
Krejsa, C. M., & Schieven, G. L. (2003) · Humana Press eBooks · doi:10.1385/1-59259-054-3:35 · Cited by 30 · see citing works
Enhancement of DNA topoisomerase I inhibitor–induced apoptosis by ursodeoxycholic acid
Ikegami, T., Matsuzaki, Y., Alrashid, M. H., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0107 · Cited by 26 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works
The Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602 · see citing works
“When ROS levels are too high, cell cycle arrest, senescence, and cancer cell death can occur (Ichijo et al. 1997, Moon et al. 2010).”
BackgroundROS in Cancer: The Burning Question
Chio, I. I. C., & Tuveson, D. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.004 · Cited by 532 · see citing works
The multifaceted role of reactive oxygen species in tumorigenesis
Kirtonia, A., Sethi, G., & Garg, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03536-5 · Cited by 452 · see citing works
Escobar, S. J. D. M., Fong, G. M., Winnischofer, S. M. B., Simone, M., Munoz, L., Dennis, J. M., Rocha, M. E. M., & Witting, P. K. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.022 · Cited by 33 · see citing works
- Authors
- Moon, D.-O., Kim, M.-O., Choi, Y. H., Hyun, J. W., Chang, W. Y., & Kim, G.-Y.
- Affiliations
- Jeju National University (KR)
- Dong-Eui University (KR)
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 288
- Issue
- 2
- Pages
- 204-213
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2020177773
- Cited by
- 151
- References
- 35
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 16 · 2021: 11 · 2020: 14 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 8
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science and Technology (2009-0076654)
- National Research Foundation of Korea
- Topics
- Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and biological activity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioactive natural compounds
- Keywords
- butein, chalcones, hepatocellular carcinoma, G2/M cell cycle arrest, apoptosis, reactive oxygen species, JNK signaling, ATM, Chk1, Chk2, Cdc25C, cdc2 kinase, N-acetylcysteine, glutathione, SP600125, HepG2 cells, Hep3B cells
- MeSH terms
- Acetylcysteine, Anthracenes, Antineoplastic Agents, Antioxidants, Cell Division, Cell Survival, Dose-Response Relationship, Drug, Enzyme Activation, Glutathione, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Phosphorylation, G2 Phase, Apoptosis, Reactive Oxygen Species, Cell Cycle Proteins, Chalcones, Protein Kinase Inhibitors, JNK Mitogen-Activated Protein Kinases, Cell Proliferation, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review